Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

Clinical trial NCT00067561 · COMPLETED

Trial details

NCT number: NCT00067561
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Irritable Colon Irritable Bowel Syndrome (IBS)

Start date: 2003-06-01
Primary completion: 2005-01-01
Enrollment: 702

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.